Goodwin
Sarah Solomon
- Deals
- 5
- Latest
- Aug 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 5 deals
Often works with
- Kingsley L. Taft 3 deals together
- Arman Oruc 3 deals together
- Timothy Holahan 2 deals together
- Dan Karelitz 2 deals together
- Gozde Guckaya 2 deals together
- Julia Shaver 2 deals together
- Sarah Bock 2 deals together
- James Devendorf 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Aug 2026 | Merida Biosciences | – | Eli Lilly and Company | Acquisition | Legal adviser to Merida Biosciences (target) | Announced | 2,875.0 | Biotech+1 | Eli Lilly and Company acquisition of Merida Biosciences |
| Jun 2026 | Parabilis Medicines | – | – | Placement | Legal adviser to the issuer | Completed | 75.0 | Biotech+1 | Parabilis Medicines placement |
| Apr 2026 | Kelonia Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Kelonia Therapeutics (target) | Announced | 7,000.0 | Biotech+2 | Eli Lilly and Company acquisition of Kelonia Therapeutics |
| Apr 2026 | Tubulis | EQT Life Sciences (LSP 7 fund) | Gilead Sciences | Acquisition | Legal adviser to Tubulis (target) | Announced | 3,150.0 | Biotech+2 | Gilead Sciences acquisition of Tubulis |
| Mar 2026 | Pikavation | Synnovation | Novartis | Acquisition | Legal adviser to Synnovation Therapeutics (seller) | Announced | 2,000.0 | Biotech+2 | Novartis acquisition of Pikavation |
Deals where Sarah Solomon is named on the firm's deal team, by the firm or the press.